Abiopharma

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2025 Financial Results

Arcellx - Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings

Jushi Holdings Inc. Announces Grand Opening of Second Beyond Hello™ in Cincinnati, Ohio, Expanding its Statewide Retail Footprint

New Form SCHEDULE 13G/A - Cogent Biosciences, Inc. Filed: 2026-01-21 AccNo: 0002012383-26-000802 Size: 11 KB

agilon health, inc. (AGL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Jin Medical International Ltd. Management Plans For Fireside Chat

New Form SCHEDULE 13G/A - Biophytis SA Filed: 2026-01-21 AccNo: 0002052113-26-000214 Size: 10 KB

Quest Diagnostics Named to Fortunes Worlds Most Admired Companies List for 12th Consecutive Year

New SEC Filing for Avanos Medical Inc. (NYSE:AVNS)

SILVER CASTLM-M (SLCL-M) was added to the list of traded instruments on TASE exchange

FLYING SPARK-M (FLYS-M) was added to the list of traded instruments on TASE exchange

New Form SCHEDULE 13G - Sana Biotechnology, Inc. Filed: 2026-01-21 AccNo: 0002012383-26-000786 Size: 10 KB

New Form SCHEDULE 13G/A - MASIMO CORP Filed: 2026-01-21 AccNo: 0002052113-26-000210 Size: 10 KB

Investis Notification - Smith+Nephew PLC